Repurposing FDA Approved Drugs as JNK3 Inhibitor for Prevention of Neuroinflammation Induced by MCAO in Rats

Repurposing FDA Approved Drugs as JNK3 Inhibitor for Prevention of Neuroinflammation Induced by MCAO in Rats

Zikra Zulfiqar,1 Fawad Ali Shah,1 Shagufta Shafique,2 Abdullah Alattar,3 Tahir Ali,4 Arooj Mohsin Alvi,1 Sajid Rashid,2 Shupeng Li5 1Department of Pharmacology, Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, Pakistan; 2National Center for Bioinformatics, Qua...

Full description

Bibliographic Details
Main Authors: Zulfiqar Z, Shah FA, Shafique S, Alattar A, Ali T, Alvi AM, Rashid S, Li S
Format: Article
Language:English
Published: Dove Medical Press 2020-12-01
Series:Journal of Inflammation Research
Subjects:
re-purposing
in silico docking
jnk3 kinase
mcao stroke
jnk3 inhibitors
neuroinflammation
brain degeneration
Online Access:https://www.dovepress.com/repurposing-fda-approved-drugs-as-jnk3-inhibitor-for-prevention-of-neu-peer-reviewed-article-JIR

Internet

https://www.dovepress.com/repurposing-fda-approved-drugs-as-jnk3-inhibitor-for-prevention-of-neu-peer-reviewed-article-JIR

Similar Items